Zaloguj Zarejestruj się zadarmo

Accelerate Diagnostics Inc organizacji PEG

Jaka jest wartość PEG organizacji Accelerate Diagnostics Inc?

Wartość PEG organizacji Accelerate Diagnostics Inc to N/A

Jaka jest definicja PEG?



Wskaźnik cena / zysk do wzrostu (PEG) to wskaźnik P / E dla akcji podzielony przez prognozowaną stopę wzrostu swoich zysków za okres 5 lat.

The PEG ratio is calculated by dividing the P/E ratio by the company's expected earnings growth rate in the next 5 years. Since using just the P/E ratio would make high-growth companies appear overvalued relative to others, the PEG ratio is considered to be a convenient approximation. PEG is a widely employed indicator of a stock's possible true value.

Similar to P/E ratios, a lower PEG means that the stock is undervalued more. It is favored by many over the price/earnings ratio because it also accounts for growth. The PEG ratio of 1 is sometimes said to represent a fair trade-off between the values of cost and the values of growth, indicating that a stock is reasonably valued given the expected growth. A crude analysis suggests that companies with PEG values between 0 and 1 may provide higher returns. A PEG Ratio can also be a negative number if a stock's present income figure is negative, (negative earnings) or if future earnings are expected to drop (negative growth). PEG ratios calculated from negative present earnings are viewed with skepticism as almost meaningless, other than as an indication of high investment risk.

PEG firm w Health Care sektor na NASDAQ w porównaniu do Accelerate Diagnostics Inc

Czym się zajmuję organizacja Accelerate Diagnostics Inc?

accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.

Firmy z peg podobne do Accelerate Diagnostics Inc